Immunic (IMUX) Current Assets (2013 - 2026)
Immunic (IMUX) posted Current Assets of $188.8 million for Q1 2026, up 725.39% sequentially from $22.9 million in Q4 2025, and up 894.78% YoY from $19.0 million in Q1 2025.
Immunic (IMUX) Current Assets (2013 - 2026) Analysis & Trends
Immunic has reported Current Assets for 14 years, with the latest figure at $188.8 million in Q1 2026.
- Quarterly Current Assets rose 894.78% year-over-year to $188.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $188.8 million (up 894.78% YoY) and the FY2025 annual result came in at $22.9 million, down 41.86% from the prior year.
- Current Assets climbed to $188.8 million in Q1 2026 per IMUX's latest filing, from $22.9 million in the prior quarter.
- Over five years, Current Assets peaked at $188.8 million in Q1 2026 and troughed at $19.0 million in Q1 2025.
- A 5-year average of $80.2 million and a median of $85.0 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2025 and 2026: Current Assets sank 81.51% in 2025, then soared 894.78% in 2026.
- Over 5 years, Current Assets stood at $125.9 million in 2022, then tumbled by 58.26% to $52.5 million in 2023, then decreased by 25.13% to $39.3 million in 2024, then sank by 41.86% to $22.9 million in 2025, then soared by 725.39% to $188.8 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $188.8 million, $22.9 million, and $39.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - | 157.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 157.83 Mn |
| Mar 31, 2026 | 188.76 Mn |
| Dec 31, 2025 | 22.87 Mn |
| Sep 30, 2025 | 39.27 Mn |
| Jun 30, 2025 | 59.84 Mn |
| Mar 31, 2025 | 18.98 Mn |
| Dec 31, 2024 | 39.33 Mn |
| Sep 30, 2024 | 63.27 Mn |
| Jun 30, 2024 | 84.98 Mn |
| Mar 31, 2024 | 102.62 Mn |
| Dec 31, 2023 | 52.53 Mn |
| Sep 30, 2023 | 65.23 Mn |
| Jun 30, 2023 | 86.55 Mn |
| Mar 31, 2023 | 106.58 Mn |
| Dec 31, 2022 | 125.86 Mn |
| Sep 30, 2022 | 86.65 Mn |
| Jun 30, 2022 | 104.76 Mn |
| Mar 31, 2022 | 115.88 Mn |
| Dec 31, 2021 | 104.99 Mn |
| Sep 30, 2021 | 122.50 Mn |